Abstract
Disseminated varicella-zoster virus infection after organ transplantation in adults is a rare but serious event causing significant morbidity and mortality. We describe our 10-year experience of 13 cases in a single center, including risk factors for infection, lack of protection from pre-existing anti-varicella-zoster virus antibodies, and unusual modes of presentation, including disseminated intravascular coagulation. We also report our preliminary observation of resolution of infection without sequelae in 4 patients with severe disseminated varicella-zoster virus infection who were treated with the combination of intravenous acyclovir and polyspecific intravenous immunoglobulin.
MeSH terms
-
Acyclovir / therapeutic use
-
Adult
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / therapeutic use
-
Disseminated Intravascular Coagulation / virology
-
Drug Therapy, Combination
-
Female
-
Heart-Lung Transplantation / adverse effects*
-
Heart-Lung Transplantation / mortality
-
Herpes Zoster / complications
-
Herpes Zoster / drug therapy
-
Herpes Zoster / etiology*
-
Humans
-
Immunoglobulins, Intravenous / therapeutic use
-
Injections, Intravenous
-
Male
-
Middle Aged
-
Pulmonary Fibrosis / complications
-
Pulmonary Fibrosis / virology
-
Respiratory Insufficiency / etiology
-
Respiratory Insufficiency / mortality
-
Retrospective Studies
Substances
-
Antiviral Agents
-
Immunoglobulins, Intravenous
-
Acyclovir